Business & Scientific Resources

Your Company's Response to Coronavirus

As cases of coronavirus (COVID-19) continue to increase around the world, this resource center is designed to keep you informed on key information to keep your employees safe and business operating. This information will be regularly updated, check back often.

  • Show All
Search
Results
CMA, on behalf of BARDA, solicits proposals for the advanced research and development of medical countermeasures (MCM) for chemical, biological, radiological and nuclear (CBRN) agents, pandemic influenza, and emerging infectious diseases that threaten the U.S. civilian population
The National Biodefense Strategy is the nation's plan for ensuring that the country is prepared for, responding to, and recovering from health incidents such as these. The DOE contributes science and technology to support these efforts
National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on COVID-19
The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks.
BARDA is temporarily suspending AOIs 1-3 as part of its EZ-BAA (BAA-20-100-SOL-0002) but is now accepting abstract submissions for AOI #4: 2019-nCoV.
BARDA added new topics under its temporary AOI #4: COVID-19 as part of its EZ-BAA (BAA-20-100-SOL-0002).
BSAC is launching a COVID-19 funding call to support researchers in better understanding and addressing COVID-19 outbreak.
The CDC, with over 70 years of experience as the U.S. NPHI, is helping countries around the world increase surveillance, laboratory, and outbreak response capacity to improve recognition of and response to health threats.
The Centers for Disease Control and Prevention (CDC), National Center of Immunization and Respiratory Diseases (NCIRD) issues this Broad Agency Announcement (BAA) under the provisions of FAR 35.016 and FAR 6.102 which provides for the competitive selection of research proposals. 
Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health
CEPI is announcing a funding opportunity for the rapid development of vaccines against COVID-19. This is a rolling call now open till at least June 30th, 2020. 
Bill & Melinda Gates Foundation, Wellcome, and Mastercard have launched Therapeutics Accelerator, an initiative to speed up development and access to therapies.
Last update: Tuesday, June 2, 2020 @ 12:29 pm EDT